Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services

Janetta M. Astone, Shiela M. Strauss, Holly Hagan, Don Des Jarlais

Research output: Contribution to journalArticle

Abstract

The hepatitis C virus (HCV) continues to penetrate populations within the United States, especially within the drug-abusing population. Therefore, drug users need access to HCV testing and medical care, and drug treatment programs are well situated to provide these services. Because directors of these programs are gatekeepers who can influence decisions about service provision, their beliefs about the value of providing particular services for drug treatment program patients are of considerable importance. Directors of 121 outpatient drug treatment programs throughout the United States responded to an in-depth telephone survey that included questions on their beliefs about providing HCV services in drug treatment programs. We constructed an eight-item scale to examine these beliefs and investigated the relationship between them and the actual HCV services offered. Overall, directors were moderately supportive of the provision of HCV medical services (on-site or through referral) during drug treatment. Our findings indicate that there is a positive significant relationship between director's beliefs and the provision of HCV antibody testing, follow-up testing, and the provision of HCV medication.

Original languageEnglish (US)
Pages (from-to)783-797
Number of pages15
JournalAmerican Journal of Drug and Alcohol Abuse
Volume30
Issue number4
DOIs
StatePublished - 2004

Fingerprint

Hepatitis C
Hepacivirus
Outpatients
Pharmaceutical Preparations
Therapeutics
Hepatitis C Antibodies
Drug Users
Telephone
Population
Referral and Consultation

Keywords

  • Beliefs
  • Drug treatment directors
  • Hepatitis C
  • Outpatient drug treatment

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Clinical Psychology

Cite this

@article{7717e687dfb44cc385d05defaa812f98,
title = "Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services",
abstract = "The hepatitis C virus (HCV) continues to penetrate populations within the United States, especially within the drug-abusing population. Therefore, drug users need access to HCV testing and medical care, and drug treatment programs are well situated to provide these services. Because directors of these programs are gatekeepers who can influence decisions about service provision, their beliefs about the value of providing particular services for drug treatment program patients are of considerable importance. Directors of 121 outpatient drug treatment programs throughout the United States responded to an in-depth telephone survey that included questions on their beliefs about providing HCV services in drug treatment programs. We constructed an eight-item scale to examine these beliefs and investigated the relationship between them and the actual HCV services offered. Overall, directors were moderately supportive of the provision of HCV medical services (on-site or through referral) during drug treatment. Our findings indicate that there is a positive significant relationship between director's beliefs and the provision of HCV antibody testing, follow-up testing, and the provision of HCV medication.",
keywords = "Beliefs, Drug treatment directors, Hepatitis C, Outpatient drug treatment",
author = "Astone, {Janetta M.} and Strauss, {Shiela M.} and Holly Hagan and {Des Jarlais}, Don",
year = "2004",
doi = "10.1081/ADA-200037544",
language = "English (US)",
volume = "30",
pages = "783--797",
journal = "American Journal of Drug and Alcohol Abuse",
issn = "0095-2990",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services

AU - Astone, Janetta M.

AU - Strauss, Shiela M.

AU - Hagan, Holly

AU - Des Jarlais, Don

PY - 2004

Y1 - 2004

N2 - The hepatitis C virus (HCV) continues to penetrate populations within the United States, especially within the drug-abusing population. Therefore, drug users need access to HCV testing and medical care, and drug treatment programs are well situated to provide these services. Because directors of these programs are gatekeepers who can influence decisions about service provision, their beliefs about the value of providing particular services for drug treatment program patients are of considerable importance. Directors of 121 outpatient drug treatment programs throughout the United States responded to an in-depth telephone survey that included questions on their beliefs about providing HCV services in drug treatment programs. We constructed an eight-item scale to examine these beliefs and investigated the relationship between them and the actual HCV services offered. Overall, directors were moderately supportive of the provision of HCV medical services (on-site or through referral) during drug treatment. Our findings indicate that there is a positive significant relationship between director's beliefs and the provision of HCV antibody testing, follow-up testing, and the provision of HCV medication.

AB - The hepatitis C virus (HCV) continues to penetrate populations within the United States, especially within the drug-abusing population. Therefore, drug users need access to HCV testing and medical care, and drug treatment programs are well situated to provide these services. Because directors of these programs are gatekeepers who can influence decisions about service provision, their beliefs about the value of providing particular services for drug treatment program patients are of considerable importance. Directors of 121 outpatient drug treatment programs throughout the United States responded to an in-depth telephone survey that included questions on their beliefs about providing HCV services in drug treatment programs. We constructed an eight-item scale to examine these beliefs and investigated the relationship between them and the actual HCV services offered. Overall, directors were moderately supportive of the provision of HCV medical services (on-site or through referral) during drug treatment. Our findings indicate that there is a positive significant relationship between director's beliefs and the provision of HCV antibody testing, follow-up testing, and the provision of HCV medication.

KW - Beliefs

KW - Drug treatment directors

KW - Hepatitis C

KW - Outpatient drug treatment

UR - http://www.scopus.com/inward/record.url?scp=9644274204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644274204&partnerID=8YFLogxK

U2 - 10.1081/ADA-200037544

DO - 10.1081/ADA-200037544

M3 - Article

VL - 30

SP - 783

EP - 797

JO - American Journal of Drug and Alcohol Abuse

JF - American Journal of Drug and Alcohol Abuse

SN - 0095-2990

IS - 4

ER -